低分子肝素相对分子质量测定用对照品的研制

目的: 制备类似WHO的附带一宽分布标样表的低分子肝素(low molecular weight heparin,LMWH)相对分子质量测定用对照品。 方法: 采用肝素酶Ι控制降解肝素得到宽分布低分子的肝素片段混合物,并以WHO LMWH相对分子质量对照品为对照,采用高效分子排阻色谱法绘制自制相对分子质量与累积面积百分比的量表。分别利用该自制对照品与WHO对照品检测4种不同工艺制备的LMWH相对分子质量。 结果: 自制LMWH相对分子质量对照品与WHO相对分子质量对照品的校正曲线基本重合在一起,2种对照品测定的4种LMWH相对分子质量结果十分接近。 结论: 自制的LMWH相对分子质量测定用对照品可以用于LMWH相对分子质量的测定,为LMWH相对分子质量测定用对照品国产化奠定了基础。

Objective: To establish a relative molecular mass calibrator with a broad standard table for low molecular mass heparin(LMWH). Methods: LMWH relative molecular mass calibrator with broad distribution was produced through controlled degradation of heparin sodium by heparinase I.With the WHO calibrator as the reference standard,a broad standard table for the prepared calibrator was constructed by high performance size exclusive chromatography(HPSEC).To evaluate the feasibility of the latter,molecular mass profiles of four LMWHs obtained with different methods were determined by WHO LMWH calibrator and the prepared calibrator. Results: The calibration curves of the prepared calibrator coincided with the WHO calibrator in general.Relative molecular mass of LMWHs determined by the prepared calibrator agreed well with that of the WHO calibrator. Conclusion: The prepared calibrator was suitable for routine quality control of molecular mass determination for commercial LMWH products.

1 Van Dedem G.Collaborative assay of heparin molecular weights by high performance size exclusion chromatography.Report,Diosynth BV,Oss,The Netherlands,1985
2 Sugisaka N,Petrasek FJ.Rapid molecular size characterization of heparins by high pressure liquid chromatography.Fed Proc,1977,36:89
3 Harenberg J,Jan X,Vries DE.Characterization of heparins by high performance size exclusion liquid chromatography.J Chromatogr A,1983,261:287
4 Muller D,Ndoume,Jozefonvicz.High-pressure size-exclusion chromatography of anticoagulant materials.J Chromatogr A,1984,297:351
5 DU Shan-shan(杜姗姗),CUI Hui-fei(崔慧斐).An introduction of methods for determination of relative molecular mass of low molecular weight heparin(低分子肝素相对分子质量测定方法).Chin J Pharm Anal(药物分析杂志),2011,31 (2):402
6 LÜ Zhi-hua(吕志华),YU Guang-li(于广利),ZHAO Xia(赵峡),et al.The influence of standards on HPGPC determining the molecular weight of a polysaccharide(不同对照品对HPGPC法测定多糖相对分子质量的影响).Chin New Drugs J (中国新药杂志),2002,11 (3):220
7 Jeske W,Ahsan A,Fareed J.Molecular weight profiling of low molecular weight heparins utilizing a heparinase degraded oligosaccharide mixture as a calibrator.Thromb Res,1993,70 (1):39
8 Mulloy B,Gee C,Wheeler SF,et al.Molecular weight measurements of low molecular weight heparins by gel permeation chromatography. J Thromb Haemost,1997,77 (4):668
9 Mulloy B,Heath A,Emmanulle M,et al.A collaborative study to establish the 2nd intermational standard low molecular weight heparin for molecular weight calibration.Expert Committee on Biological Standardization,Geneva,2007
10 CAO Ping(曹苹),ZHANG Lin-sheng(张麟生).Heparin effect of anticoagulation and antithrombotic(低分子肝素的抗凝与抗血栓作用).Chin J Hosp Pharm(中国医院药学杂志),2001,21 (5):289
11 LI Jing(李京),FAN Hui-hong(范慧红),XU Kang-sen(徐康森).Study on the current status and the quality standard of low molecular weight heparin(低分子肝素药用现状及质量标准概况). Chin J Biochem Pharm(中国生化药物杂志),2004,25 (1):53
12 Ye FC,Kuang Y,Chen S,et al.Characteristics of low molecular weight heparin production by an ultrafiltration membrane bioreactor using maltose binding protein fused heparinaseⅠ.Biochem Eng J,2009,46:193
13 WHO International Standard 2^nd International Standard Low Molecular Weight Heparin for Molecular Weight Calibration,NIBSC code 05/112,Instructions for Use.National Institute for Biological Standards (NIBSC),2008,Version 3.0